Medplus Health Services Limited

Medplus Health Services schedules earnings call for Q2 & H1 FY26 results on November 03, 2025

Medplus Health Services Limited has scheduled an earnings call on November 03, 2025, to discuss its un-audited financial results for the quarter and half-year ended September 30, 2025.

Medplus subsidiary receives 7-day drug license suspension in Andhra Pradesh

Medplus subsidiary, Optival Health Solutions, received a 7-day drug license suspension for a store in Andhra Pradesh due to a violation, with a potential revenue loss of ₹ 0.91 lakhs.

Medplus subsidiary Optival Health Solutions faces 3-day drug license suspension in Chhattisgarh

Medplus subsidiary Optival Health Solutions received a 3-day drug license suspension for a Chhattisgarh store due to a violation, incurring an estimated ₹0.39 lakh revenue loss.

Medplus subsidiary receives 3-day drug license suspension in Chhattisgarh

Medplus subsidiary, Optival Health Solutions, received a 3-day drug license suspension for a store in Chhattisgarh due to a violation, potentially losing ₹0.39 lakhs in revenue.

Subsidiary Optival Health Solutions Receives Drug License Suspension Orders

Medplus Subsidiary Optival Health Solutions Faces 15-Day Drug License Suspension in Maharashtra

Medplus subsidiary faces 7-day drug license suspension for one store, minor revenue impact

Medplus subsidiary receives two drug license suspension orders in Karnataka and Andhra Pradesh

Subsidiary Optival Health Solutions Receives Drug License Suspension Orders

MedPlus Health Services Conducts 19th Annual General Meeting

Optival Health Solutions Receives Suspension Order for Drug License

Medplus Subsidiary Receives Two Drug License Suspension Orders in Telangana

Medplus Subsidiary Faces 4-Day Drug License Suspension in Telangana, Rs 9.08 Lakh Revenue Loss

Medplus subsidiary, Optival, receives suspension order for drug license.

Medplus subsidiary receives suspension orders for drug licenses in Karnataka

Medplus subsidiary receives suspension order for drug license.

Medplus subsidiary receives suspension order for drug license in Telangana

MedPlus Releases Business Responsibility and Sustainability Report for FY25

Medplus Health Services Announces 19th Annual General Meeting on Sept 15, 2025

Medplus subsidiary Optival Health Solutions receives drug license suspensions in Karnataka and Maharashtra

Medplus subsidiary receives suspension order for drug license.

Medplus subsidiary, Optival, receives suspension orders for drug licenses.

Medplus Health Services Uploads Audio Recording of Q1 FY26 Earnings Call

Optival Health Solutions Receives Drug License Suspension Orders

Medplus subsidiary Optival Health Solutions receives one-day drug license suspension in Karnataka

Medplus to Host Earnings Call for Q1 FY26 Results on August 4, 2025

Subsidiary Optival Health Solutions Receives Drug License Suspension

Medplus Subsidiary Faces 3-Day Drug License Suspension in Tamil Nadu, Minor Revenue Impact